TSHA - Taysha Gene Therapies, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$11.50
DETAILS
HIGH:
$13.00
LOW:
$11.00
MEDIAN:
$11.00
CONSENSUS:
$11.50
UPSIDE:
109.47%
Institutional Holders (13F)
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-04-10 | Nagendran Sukumar | director, officer: President and Head of R&D | M-Exempt | 19,021 | $1.71 | $33K |
| 2026-04-10 | Nagendran Sukumar | director, officer: President and Head of R&D | SELL | 200,000 | $4.46 | $892K |
| 2026-02-04 | Alam Kamran | officer: CHIEF FINANCIAL OFFICER | SELL | 1,655 | $4.52 | $7K |
| 2026-01-26 | Nagendran Sukumar | director, officer: President and Head of R&D | SELL | 26,918 | $4.61 | $124K |
| 2026-01-23 | Nolan Sean P. | director, officer: Chief Executive Officer | SELL | 136,789 | $4.75 | $650K |
| 2026-01-23 | Nagendran Sukumar | director, officer: President and Head of R&D | SELL | 89,132 | $4.75 | $423K |
| 2026-01-26 | Nolan Sean P. | director, officer: Chief Executive Officer | SELL | 41,312 | $4.61 | $190K |
| 2026-01-23 | Alam Kamran | officer: CHIEF FINANCIAL OFFICER | SELL | 78,968 | $4.75 | $375K |
| 2026-01-26 | Alam Kamran | officer: CHIEF FINANCIAL OFFICER | SELL | 23,849 | $4.61 | $110K |
| 2026-01-12 | Alam Kamran | officer: CHIEF FINANCIAL OFFICER | A-Award | 359,000 | -- | -- |
| 2026-01-12 | Nagendran Sukumar | director, officer: President and Head of R&D | M-Exempt | 88,676 | $1.71 | $152K |
| 2026-01-12 | Nagendran Sukumar | director, officer: President and Head of R&D | SELL | 200,000 | $4.71 | $942K |
| 2026-01-12 | Nagendran Sukumar | director, officer: President and Head of R&D | M-Exempt | 111,324 | $0.70 | $78K |
| 2026-01-12 | Nagendran Sukumar | director, officer: President and Head of R&D | A-Award | 427,000 | -- | -- |
| 2026-01-12 | Alam Kamran | officer: CHIEF FINANCIAL OFFICER | A-Award | 231,000 | $4.86 | $1.1M |
| 2026-01-12 | Nolan Sean P. | director, officer: Chief Executive Officer | A-Award | 1,008,000 | -- | -- |
| 2026-01-12 | Nolan Sean P. | director, officer: Chief Executive Officer | A-Award | 648,000 | $4.86 | $3.1M |
| 2026-01-12 | Nagendran Sukumar | director, officer: President and Head of R&D | A-Award | 274,000 | $4.86 | $1.3M |
| 2025-11-28 | Nagendran Sukumar | director, officer: President and Head of R&D | SELL | 110,125 | $4.75 | $523K |
| 2025-12-01 | Nagendran Sukumar | director, officer: President and Head of R&D | SELL | 260,047 | $4.51 | $1.2M |
| 2025-12-01 | Nagendran Sukumar | director, officer: President and Head of R&D | M-Exempt | 260,047 | $1.71 | $445K |
| 2025-11-28 | Nagendran Sukumar | director, officer: President and Head of R&D | M-Exempt | 39,953 | $1.71 | $68K |
| 2025-11-28 | Nagendran Sukumar | director, officer: President and Head of R&D | M-Exempt | 70,172 | $0.70 | $49K |
| 2025-09-10 | Nagendran Sukumar | director, officer: President and Head of R&D | SELL | 200,000 | $3.23 | $646K |
| 2025-09-10 | Nagendran Sukumar | director, officer: President and Head of R&D | M-Exempt | 41,150 | $0.70 | $29K |